Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danlong oral liquid for asthma (heat asthma syndrome)
ChiCTR2300073928Phase 4Completed
- Sponsor
- China-Japan Friendship Hospital
- Start
- Jul 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Danlong in asthma, sponsored by China-Japan Friendship Hospital. Primary endpoint: Lung function. Started Jul 2023; status: completed.
02
Drugs
Danlong
03
Conditions
asthma
Beyond the preview
Go deeper on ChiCTR2300073928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073928.